| 0 |
SCROTAL HAEMATOCOELE |
1 |
0.0120 |
| 1 |
BLOOD VISCOSITY ABNORMAL |
1 |
0.0105 |
| 2 |
KYPHOSCOLIOSIS |
1 |
0.0038 |
| 3 |
BLOOD VISCOSITY DECREASED |
1 |
0.0030 |
| 4 |
TINEA CRURIS |
1 |
0.0020 |
| 5 |
NAIL BED BLEEDING |
1 |
0.0018 |
| 6 |
BLOOD IMMUNOGLOBULIN M INCREASED |
1 |
0.0016 |
| 7 |
PNEUMOCOCCAL SEPSIS |
1 |
0.0015 |
| 8 |
ORTHOSTATIC INTOLERANCE |
1 |
0.0014 |
| 9 |
PENILE HAEMORRHAGE |
1 |
0.0012 |
| 10 |
DRUG DISPENSED TO WRONG PATIENT |
1 |
0.0010 |
| 11 |
ONYCHALGIA |
1 |
0.0010 |
| 12 |
LEFT ATRIAL DILATATION |
1 |
0.0008 |
| 13 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 14 |
CATAPLEXY |
1 |
0.0007 |
| 15 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 16 |
PNEUMONIA PNEUMOCOCCAL |
1 |
0.0007 |
| 17 |
TOTAL LUNG CAPACITY DECREASED |
1 |
0.0006 |
| 18 |
LAZINESS |
1 |
0.0006 |
| 19 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 20 |
FLAT AFFECT |
1 |
0.0004 |
| 21 |
STARING |
1 |
0.0004 |
| 22 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 23 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 24 |
WOUND SECRETION |
1 |
0.0003 |
| 25 |
PARONYCHIA |
1 |
0.0002 |
| 26 |
FEELING OF DESPAIR |
1 |
0.0002 |
| 27 |
MEDICATION RESIDUE PRESENT |
1 |
0.0002 |
| 28 |
SCOLIOSIS |
1 |
0.0002 |
| 29 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 30 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 31 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 32 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 33 |
TENDERNESS |
1 |
0.0001 |
| 34 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 35 |
ASPIRATION |
1 |
0.0001 |
| 36 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 37 |
ATAXIA |
1 |
0.0001 |
| 38 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 39 |
ABASIA |
2 |
0.0001 |
| 40 |
TOOTH INFECTION |
1 |
0.0001 |
| 41 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 42 |
APHONIA |
1 |
0.0001 |
| 43 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 44 |
ULCER |
1 |
0.0001 |
| 45 |
OBESITY |
1 |
0.0001 |
| 46 |
ABSCESS |
1 |
0.0001 |
| 47 |
FOOT FRACTURE |
1 |
0.0001 |
| 48 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 49 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 50 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 51 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 52 |
AGEUSIA |
1 |
0.0000 |
| 53 |
DEAFNESS |
1 |
0.0000 |
| 54 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 55 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 56 |
HYPERSOMNIA |
1 |
0.0000 |
| 57 |
STOMATITIS |
2 |
0.0000 |
| 58 |
EPILEPSY |
1 |
0.0000 |
| 59 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 60 |
HEAD INJURY |
1 |
0.0000 |
| 61 |
SKIN DISORDER |
1 |
0.0000 |
| 62 |
URINARY RETENTION |
1 |
0.0000 |
| 63 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 64 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 65 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 66 |
DISORIENTATION |
1 |
0.0000 |
| 67 |
POLLAKIURIA |
1 |
0.0000 |
| 68 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 69 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 70 |
CELLULITIS |
1 |
0.0000 |
| 71 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 72 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 73 |
HYPONATRAEMIA |
1 |
0.0000 |
| 74 |
DISCOMFORT |
1 |
0.0000 |
| 75 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 76 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 77 |
INJURY |
1 |
0.0000 |
| 78 |
SLEEP DISORDER |
1 |
0.0000 |
| 79 |
UNDERDOSE |
1 |
0.0000 |
| 80 |
ACNE |
1 |
0.0000 |
| 81 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 82 |
THROMBOSIS |
1 |
0.0000 |
| 83 |
BALANCE DISORDER |
1 |
0.0000 |
| 84 |
SWELLING |
1 |
0.0000 |
| 85 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 86 |
CONTUSION |
1 |
0.0000 |
| 87 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 88 |
BACK PAIN |
2 |
0.0000 |
| 89 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 90 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 91 |
HYPERHIDROSIS |
1 |
0.0000 |
| 92 |
DRY SKIN |
1 |
0.0000 |
| 93 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 94 |
COUGH |
2 |
0.0000 |
| 95 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 96 |
PNEUMONIA |
2 |
0.0000 |
| 97 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 98 |
MYALGIA |
1 |
0.0000 |
| 99 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 100 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 101 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 102 |
ASTHENIA |
2 |
0.0000 |
| 103 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 104 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 105 |
ALOPECIA |
1 |
0.0000 |
| 106 |
ERYTHEMA |
1 |
0.0000 |
| 107 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 108 |
WEIGHT INCREASED |
1 |
0.0000 |
| 109 |
DECREASED APPETITE |
1 |
0.0000 |
| 110 |
FATIGUE |
3 |
0.0000 |
| 111 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 112 |
HEADACHE |
2 |
0.0000 |
| 113 |
FALL |
1 |
0.0000 |
| 114 |
PRURITUS |
1 |
0.0000 |
| 115 |
RASH |
1 |
0.0000 |
| 116 |
DIZZINESS |
1 |
0.0000 |
| 117 |
PAIN |
1 |
0.0000 |
| 118 |
DIARRHOEA |
1 |
0.0000 |
| 119 |
NAUSEA |
1 |
0.0000 |